Nadège Pelletier
Chief Tech/Sci/R&D Officer chez BARINTHUS BIOTHERAPEUTICS PLC
Fortune : - $ au 31/03/2024
Profil
Nadège Pelletier is currently the Chief Scientific Officer at Barinthus Biotherapeutics Plc.
Prior to this, she worked as a Senior Principal Scientist at Novartis Institutes for Biomedical Research, Inc. She holds a doctorate degree from Université Claude Bernard Lyon 1 and a graduate degree from École Normale Supérieure de Lyon.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
13/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Nadège Pelletier
Sociétés | Poste | Début |
---|---|---|
BARINTHUS BIOTHERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 01/02/2023 |
Anciens postes connus de Nadège Pelletier
Sociétés | Poste | Fin |
---|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Nadège Pelletier
Université Claude Bernard Lyon 1 | Doctorate Degree |
École Normale Supérieure de Lyon | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BARINTHUS BIOTHERAPEUTICS PLC | Health Technology |
Entreprise privées | 1 |
---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |